St. Jude Children's Research Hospital, a global leader in life science research, has partnered with Rockland Immunochemicals, with the intent to aide the fostering and development of disease prevention guidelines and the discovery of novel therapies.
The included antibodies are the result of basic and translational research. These antibodies and reagents were developed using cutting-edge experimental approaches to advance the understanding of the basic molecular pathways used to deal with stress and prevent diseases. These enhanced bioreagents are available to improve your biomedical research.
To learn more about Rockland and St. Jude's collaboration, visit: http://www.rockland-inc.com/stjude-collaboration/
View the Full Newsletter